ADC Therapeutics
ADCT • NYSE
ADC Therapeutics is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Ameet Mallik, with a market cap of $477.7M.
Market Cap$477.7M
Employees274.0
CEOAmeet Mallik
CountrySwitzerland
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
ADC Therapeutics FAQ
Common questions about ADC Therapeutics
ADC Therapeutics is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $19.9M.
ADC Therapeutics has approximately 274 employees.